Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease

Journal of Infectious Diseases

Volumn 192, Issue 2, 2005, Pages 344-349

  Burns, Jane C ^a   Shimizu, Chisato ^a   Gonzalez, Enrique ^b,c   Kulkarni, Hemant ^b,c   Patel, Sukeshi ^b,c   Shike, Hiroko ^a   Sundel, Robert S ^d   Newburger, Jane W ^d   Ahuja, Sunil K ^b,c,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e VA HIV/AIDS Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL3L1 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; LIGAND; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; CORONARY ARTERY ANEURYSM; DISEASE PREDISPOSITION; EUROPE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SYSTEMIC VASCULITIS;

CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MODELS, GENETIC; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTORS, CCR5; VARIATION (GENETICS); VASCULITIS;

EID: 22244433460     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430953     Document Type: Article

References (42)

1. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307:1434-40.
2. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002; 13:455-81.
3. O'Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 2000; 177:99-111.
4. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273:1856-62.
5. Lucotte G, Dieterlen F. More about the Viking hypothesis of origin of the Δ32 mutation in the CCR5 gene conferring resistance to HIV-1 infection. Infect Genet Evol 2003; 3:293-5.
6. Johnston JB, Barrett JW, Chang W, et al. Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J Virol 2003; 77:5877-88.
7. Galvani AP, Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-Δ32 HIV-resistance allele. Proc Natl Acad Sci USA 2003; 100:15276-9.
8. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112:495-501.
9. Bronstein DE, Dille AN, Austin JP, Williams CM, Palinkas LA, Burns JC. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J 2000; 19:1087-91.
10. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome in Hawaii. Pediatr Infect Dis 2005; 24:429-33.
11. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
12. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Paediatr 2003; 92:694-7.
13. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr 2001; 90:40-4.
14. Mori M, Miyamae T, Kurosawa R, Yokota S, Onoki H. Two-generation Kawasaki disease: mother and daughter. J Pediatr 2001; 139:754-6.
15. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110:2747-71.
16. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133:254-8.
17. Quasney MW, Bronstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res 2001; 49:686-90.
18. Heath EM, Morken NW, Campbell KA, Tkach D, Boyd EA, Strom DA. Use of buccal cells collected in mouthwash as a source of DNA for clinical testing. Arch Pathol Lab Med 2001; 125:127-33.
19. Gonzalez E, Bamshad M, Sato N, et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 1999; 96:12004-9.
20. O'Connell JR, Weeks DE. PedCheck: a program for identifying genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63:259-66.
21. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and non-parametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58:1347-63.
22. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52:506-16.
23. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59:323-36.
24. Cordell HJ, Barratt BJ, Clayton DG. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol 2004; 26: 167-85.
25. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child 1998; 78:33-9.
26. Pelkonen P, Salo E. Epidemiology of Kawasaki disease. Clin Exp Rheumatol 1994; 12(Suppl 10):S83-5.
27. Park YW, Park IS, Kim CH, et al. Epidemiologic study of Kawasaki disease in Korea, 1997-1999: comparison with previous studies during 1991-1996. J Korean Med Sci 2002; 17:453-6.
28. Du ZD, Zhang T, Liang L, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J 2002; 21: 103-7.
29. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 2002; 324:1424-5.
30. Schiller B, Fasth A, Bjorkhem G, Elinder G. Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 1995; 84:769-74.
31. Lue HC, Philip S, Chen MR, Wang JK, Wu MH. Surveillance of Kawasaki disease in Taiwan and review of the literature. Acta Paediatr Taiwan 2004; 45:8-14.
32. Feng T, Ni A, Yang G, Galvin SR, Hoffman IF, Cohen MS. Distribution of the CCR5 gene 32-base pair deletion and CCR5 expression in Chinese minorities. J Acquir Immune Defic Syndr 2003; 32:131-4.
33. Gonzalez E, Dhanda R, Bamshad M, et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 2001; 98:5199-204.
34. Li C, Yan YP, Shieh B, Lee CM, Lin RY, Chen YM. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan. J Formos Med Assoc 1997; 96:979-84.
35. Oh MD, Kim SS, Kim EY, et al. The frequency of mutation in CCR5 gene among Koreans. Int J STD AIDS 2000; 11:266-7.
36. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100-3.
37. Ansari-Lari MA, Liu XM, Metzker ML, Rut AR, Gibbs RA. The extent of genetic variation in the CCR5 gene. Nat Genet 1997; 16:221-2.
38. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995; 57:455-64.
39. Mummidi S, Bamshad M, Ahuja SS, et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA: potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000; 275:18946-61.
40. Mangano A, Gonzalez E, Dhanda R, et al. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis 2001; 183:1574-85.
41. Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr HIV Res 2003; 1:185-203.
42. Mummidi S, Ahuja SS, Gonzalez E, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998; 4:786-93.